Overview Financials News + Filings |
Recent News + Filings (All items)
Date Filed | Type | Description |
07/17/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
05/19/2023 |
10-K
| Annual Report for the period ended January 31, 2023 |
05/01/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
12/14/2022 |
10-Q
| Quarterly Report for the period ended October 31, 2022 |
09/19/2022 |
10-Q
| Quarterly Report for the period ended July 31, 2022 |
09/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
06/21/2022 |
10-Q
| Quarterly Report for the period ended April 30, 2022 |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 | Jan-31-18 |
Revenues | 0.6 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | 60.1% | 597067.7% | -74.4% | 284.1% | 18.9% | |
Cost of goods sold | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.4 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | 75.6% | 84.6% | 100.0% | -9604.5% | -56552.4% | -38211.3% |
Selling, general and administrative | 0.8 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 |
Sales and marketing | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 |
General and administrative | | | | 0.0 | 0.0 | 0.0 |
EBIT | -0.4 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT margin | -74.9% | -107.3% | -52016.1% | -9604.5% | -56552.4% | -38211.3% |
Pre-tax income | -0.4 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -0.4 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | -67.2% | -107.3% | -52016.1% | -9604.5% | -56552.4% | -38211.3% |
|
Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Shares outstanding (diluted) | 86.1 | 83.8 | 75.8 | 75.8 | 265.5 | 585.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|